NCT00350467View on ClinicalTrials.gov

A Randomized, Active-controlled, Double-blind, Parallel-Goup Study of the Efficacy and Safety of Extended Release(ER) Paliperidone in the Treatment of Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

288

Participants

Timeline

Start Date

June 30, 2006

Study Completion Date

September 30, 2007

Conditions
Acute Schizophrenia
Interventions
DRUG

ER OROS paliperidone and Olanzapine

Trial Locations (7)

Unknown

Beijing

Guangzhou

Wuhan

Nanjing

Shanghai

Suzhou

Xi'an

All Listed Sponsors
lead

Xian-Janssen Pharmaceutical Ltd.

INDUSTRY

NCT00350467 - A Randomized, Active-controlled, Double-blind, Parallel-Goup Study of the Efficacy and Safety of Extended Release(ER) Paliperidone in the Treatment of Schizophrenia | Biotech Hunter | Biotech Hunter